Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis.
Research output: Contribution to journal › Article
Details
| Authors | |
|---|---|
| Organisations | |
| Research areas and keywords | Subject classification (UKÄ) – MANDATORY
|
| Original language | English |
|---|---|
| Pages (from-to) | 706-710 |
| Journal | Journal of Neurology, Neurosurgery and Psychiatry |
| Volume | 75 |
| Issue number | 5 |
| Publication status | Published - 2004 |
| Publication category | Research |
| Peer-reviewed | Yes |
Total downloads
No data available
